THE LONG-TERM SAFETY AND EFFICACY OF TADALAFIL 5MG ONCE-DAILY IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS)

被引:0
|
作者
Donatucci, C. [1 ]
Brock, G. [2 ]
Goldfischer, E. [3 ]
Pommerville, P. [4 ]
Elion-Mboussa, A. [5 ]
Kissel, J. [5 ]
Viktrup, L. [5 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
[2] Univ Western Ontario, Dept Surg, St Josephs Hlth Care London, London, ON N6A 3K7, Canada
[3] Hudson Valley Urol, Ctr Poughkeepsie, Poughkeepsie, NY USA
[4] Can Med Clin Res Inc, Victoria, BC, Canada
[5] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S1569-9056(10)60973-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:312 / 312
页数:1
相关论文
共 50 条
  • [21] Effects of Tadalafil Once Daily on Maximum Urinary Flow Rate in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
    Roehrborn, Claus G.
    Chapple, Christopher
    Oelke, Matthias
    Cox, David
    Esler, Anne
    Viktrup, Lars
    JOURNAL OF UROLOGY, 2014, 191 (04): : 1045 - 1050
  • [22] Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia
    Rohrbough, C. R.
    Colgan, Bridget
    Gasser, Ollie
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (01) : 83 - 84
  • [23] Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Gonzalez, Ricardo R.
    Kaplan, Steven A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 609 - 617
  • [24] EFFECTS OF THE ONCE DAILY CO ADMINISTRATION OF TADALAFIL WITH FINASTERIDE FOR 6 MONTHS IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND PROSTATIC ENLARGEMENT SECONDARY TO BENIGN PROSTATIC HYPERPLASIA
    Buettner, Hartwig
    Roehrborn, Claus
    Glina, Sidney
    Esen, Adil
    Kapadia, Ketan
    Henneges, Carsten
    Wong, David
    Sorsaburu, Sebastian
    Viktrup, Lars
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 175 - 175
  • [25] Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
    McVary, Kevin T.
    Roehrborn, Claus G.
    Kaminetsky, Jed C.
    Auerbach, Stephen M.
    Wachs, Barton
    Young, Jay M.
    Esler, Anne
    Sides, Gregory D.
    Denes, Bela S.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 1401 - 1407
  • [26] Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Kose, Gokhan
    Tekin, Ilteris
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2007, 6 (01): : 34 - 36
  • [27] ADMINISTRATION OF DAILY 5MG TADALAFIL IMPROVES NOT ONLY LOWER URINARY TRACT SYMPTOMS BUT ALSO VESSEL ENDOTHELIAL FUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    Amano, Toshiyasu
    Kishikage, Takahiro
    Imao, Tetsuya
    JOURNAL OF UROLOGY, 2017, 197 (04): : E101 - E101
  • [28] ADMINISTRATION OF DAILY 5MG TADALAFIL IMPROVES NOT ONLY LOWER URINARY TRACT SYMPTOMS BUT ALSO ERECTILE AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    Amano, T.
    Imao, T.
    Kishikage, T.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01): : S22 - S23
  • [29] Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)
    Seitz, M.
    Bader, M.
    Tilki, D.
    Stief, C.
    Gratzke, C.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (02) : 123 - 133
  • [30] Management of the Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH), with Terazosin
    Mubeen, R. M.
    Ahmad, N.
    Shahzad, M.
    Nawaz, M.
    Akbar, M.
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2005, 11 (04): : 558 - 560